Clinical Predictors of Response to Tocilizumab: A Retrospective Multicenter Study.

Turk Thorac J · 2022 · PMC9450267 · PMID 35579229

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

failed to reach statistical significanceP = .058so close (0.05 < p ≤ 0.1)

C-reactive protein (CRP, mg/dL) levels tended to be lower in the survivor group; however, this failed to reach statistical significance (68.4 (32.7-157.5) vs. 113.5 (77.7-219.0), P = .058).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.